OPKO Health (OPK) Misses Q1 EPS by 18c, Revenue Beats

OPKO Health (NYSE: OPK) reported Q1 EPS of ($0.26), $0.18 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $30.1 million versus the consensus estimate of $23.13 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c